Abstract:Rapamycin is a triene macrolide antibiotic produced by Streptomyces hygroscopicus. Besides its wide application as an effective immunosuppressive agent, other important bioactivities have made rapamycin a potential drug lead for novel pharmaceutical development. However, the low titer of rapamycin in the original producer strain limits further industrialization efforts and restricts its use for other applications. Predicated on knowledge of the metabolic pathways related to rapamycin biosynthesis in S. hygroscopicus, we have rationally designed approaches to generate a rapamycin high producer strain of S. hygroscopicus HD-04-S. These have included alleviation of glucose repression, improved tolerance towards lysine and shikimic acid, and auxotrophy of tryptophan and phenylalanine through the application of stepwise UV mutagenesis. The resultant strain produced rapamycin at 450 mg/L in the shake flask scale. These fermentations were further scaled up in 120 and 20,000 L fermentors, respectively, at the pilot plant. Selected fermentation factors including agitation speed, pH, and on-line supplementation were systematically evaluated. A fed-batch strategy was established to maximize rapamycin production. With these efforts, an optimized fermentation process in the larger scale fermentor was developed. The final titer of rapamycin was 812 mg/L in the 120 L fermentor and 783 mg/L in the 20,000 L fermentor. This work highlights a high rapamycin producing strain derived by mutagenesis and subsequent screening, fermentation optimization of which has now made it feasible to produce rapamycin on an industrial scale by fermentation. The strategies developed here should also be applicable to titer improvement of other important microbial natural products on an industrial scale. Biotechnol. Bioeng. 2010; 107: 506-515. (C) 2010 Wiley Periodicals, Inc.

Rational screening for high production tacrolimus-producing strain

Generation of high rapamycin producing strain via rational metabolic pathway-based mutagenesis and further titer improvement with fed-batch bioprocess optimization.

Effect of various antibiotics on the tacrolimus producing strain

Screening of higher-yield sirolimus producer, mutant FC 904-33

Development of a yeast cell based method for efficient screening of high yield tacrolimus production strain

Rational Screen of High Kelimycin-producing Strain by Combined Conventional Mutagenesis and High-Throughput Screen Method

Rational screening of cephalosporin C high yielding producing strains

Protoplast Preparation of Trichoderma Taxi ZJUF0986 and Screening of Resistant Mutants

Improvement of FK 506 Production by Selection of 4-Aminobutyric Acid-tolerant Mutant and Optimization of its Fermentation Using Response Surface Methodology

Enhancing the Production of Tacrolimus by Engineering Target Genes Identified in Important Primary and Secondary Metabolic Pathways and Feeding Exogenous Precursors

Improvement of Pristinamycin-Producing Streptomyces Pristinaespiralis by Rational Screening

Screening of High Pristinamycin-Producing Strain by Combined Mutation

High throughput screening of high-yield cephalosporin C producing strain by mutagenesis using atmospheric and room temperature plasma(ARTP)

60Co Γ-Irradiation MUTATION INDUCTION FOR SCREENING OF AVILAMYCIN STRAINS WITH HIGH PRODUCTIVITY AND ITS CULTURE MEDIUM OPTIMIZATION

Combining Metabolomics and Network Analysis to Improve Tacrolimus Production in Streptomyces Tsukubaensis Using Different Exogenous Feedings

Half-rational Screening of Mutant Overproducing Coronatine

Screening of Micromonospora Purpura Strain Producing Micronomicin with Resistance to Micronomicin on the Isolation Medium

Screening of high-salinomycin-yield mutants of Streptomyces albus by self-resistance methodology

Identification and Metabolomic Analysis of Chemical Elicitors for Tacrolimus Accumulation in Streptomyces Tsukubaensis

Screening of L- Corydalmine High- Producing Strain Catalyzing the Biotransformation of L- Tetrahydropalmatine by UV Mutatigenesis